Stockscreener 앱 받기
6.70
2.92%
0.19
시간 외 거래:
6.57
-0.13
-1.94%
전일 마감가:
$6.51
열려 있는:
$6.44
하루 거래량:
563.88K
Relative Volume:
0.67
시가총액:
$651.45M
수익:
$1.91M
순이익/손실:
$-94.23M
주가수익비율:
-2.6269
EPS:
-2.5505
순현금흐름:
$-79.76M
1주 성능:
+8.24%
1개월 성능:
+17.96%
6개월 성능:
+72.24%
1년 성능:
+48.23%
1일 변동 폭
$6.3352
$6.72
1주일 범위
$6.20
$6.7548
52주 변동 폭
$2.85
$6.9494
Anteris Technologies Global Corp Stock (AVR) Company Profile
명칭
Anteris Technologies Global Corp
전화
651-493-0606
주소
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
6.70 | 632.98M | 1.91M | -94.23M | -79.76M | -2.5505 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-12 | 재개 | Cantor Fitzgerald | Overweight |
| 2026-03-11 | 개시 | Wells Fargo | Overweight |
| 2025-01-08 | 개시 | Lake Street | Buy |
| 2025-01-07 | 개시 | Barclays | Overweight |
| 2025-01-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
모두보기
Anteris Technologies Global Corp 주식(AVR)의 최신 뉴스
Anteris Technologies Global Starts US PARADIGM Trial Enrolment - smallcaps.com.au
Why Market Is Bullish on Anteris Technologies (ASX:AVR) Today - Kalkine
Anteris adds seasoned finance leaders to board as structural heart push continues - TipRanks
Anteris Technologies Global Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Anteris Announces Results for the First Quarter of 2026 - The Manila Times
Heart valve firm Anteris raises $320M to drive global DurAVR trial - Stock Titan
AVR: DurAVRⓇ THV system adoption grows, with Q1 2026 payments to related parties at US$2.3M - TradingView
Anteris Technologies Global Corp. 1Q 2026: Revenue $494K, EPS ($0.28) — 10-Q Summary - TradingView
Anteris Technologies (Nasdaq: AVR) posts Q1 2026 loss, raises $320M for DurAVR trial - Stock Titan
Anteris Technologies Global Corp at Barclays Global Healthcare Conference Transcript - GuruFocus
Anteris Technologies Global Corp expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Anteris secures US Medicare coverage for PARADIGM Trial as DurAVR study advances | ASX:AVR, NASDAQ:AVR - Proactive financial news
AVR Stock Price, Quote & Chart | ANTERIS TECHNOLOGIES GLOBAL (NASDAQ:AVR) - ChartMill
Anteris Technologies Enrolls First US Patients in PARADIGM Trial; Shares Up 6% - marketscreener.com
First U.S. patients enrolled in Anteris heart valve trial By Investing.com - Investing.com South Africa
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial - The Manila Times
Anteris Technologies begins U.S. enrollment in heart valve trial - StreetInsider
First U.S. patients enter Anteris heart valve trial for stenosis - Stock Titan
Anteris Treats First U.S. Patients in Pivotal DurAVR Heart Valve Trial - TipRanks
Anteris Sees CDI Decline as Investors Shift to Nasdaq-Listed Common Stock - TipRanks
Sio Capital (AVR) reports 5.38M shares, 5.54% stake as of Mar 31, 2026 - Stock Titan
Anteris Ends v2vmedtech Development Agreement, Limits Exposure - The Globe and Mail
Anteris Technologies Global Corp. (NASDAQ: AVR) registers 9.10M shares; discontinues v2v contributions - Stock Titan
Anteris Technologies Exits v2vmedtech Development Agreement, to Pay $400,000 Break Fee, Shares Up 3% - marketscreener.com
Anteris Technologies Exits V2vmedtech Development Agreement, to Pay $400,000 Break Fee, Shares Up 3% - 富途牛牛
Anteris Walks Away From v2vmedtech Funding Deal With Limited Financial Impact - TipRanks
Anteris Technologies ends development agreement with v2vmedtech, pays $400,000 fee By Investing.com - Investing.com South Africa
Anteris Technologies ends development agreement with v2vmedtech, pays $400,000 fee - Investing.com
Anteris Issues 110,236 Restricted Stock Units Under Employee Incentive Plan - TipRanks
Anteris Technologies Global (NASDAQ:AVR) Trading 5.7% HigherWhat's Next? - MarketBeat
Anteris Technologies Global CorpMilestone - Moomoo
Anteris Technologies Global Corp. Secures Cms Reimbursement Eligibility for Paradigm Trial - marketscreener.com
Anteris secures US Medicare coverage for PARADIGM Trial as DurAVR study advances - Proactive financial news
Anteris Wins CMS Reimbursement to Advance PARADIGM Heart Valve Trial in U.S. - TipRanks
Anteris Technologies (AVR) registers 9.10M-share resale; files 181K sq ft lease - Stock Titan
Anteris Technologies Expands Share Base via Conversion of Unquoted Securities - TipRanks
Anteris Technologies proposes $200M stock offering, plans Medtronic investment - MSN
Purchase/sale of business (net) of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Wells Fargo initiates coverage of Anteris Technologies Global (AVR) with overweight recommendation - MSN
ANTERIS TECHNOLOGIES GLOBAL CORP-ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT - Moomoo
Anteris Technologies Global Corp. (AVR) Files 8-K Announcing Material Definitive Agreement – Nasdaq-Listed Emerging Growth Company - Minichart
Anteris Technologies Global enters long-term lease for Minnesota facility By Investing.com - Investing.com India
Anteris Technologies Global prices $200M public offering and concurrent $90M Medtronic placement - MSN
Anteris Flags Material Agreement in SEC Filing as DurAVR Valve Advances - TipRanks
Anteris Technologies Signs Major Brooklyn Park Facility Lease - TipRanks
Anteris Technologies Global enters long-term lease for Minnesota facility - Investing.com
[8-K] Anteris Technologies Global Corp. Reports Material Event - Stock Titan
Anteris Technologies Looks Bullish If DurAVR's PARADIGM Delivers - Seeking Alpha
Anteris (AVR) Stock Watch: Key Levels (On the Radar) 2026-04-16Open Stock Signal Network - UBND thành phố Hải Phòng
Anteris Technologies Global (NASDAQ:AVR) Trading Down 5.4%Here's What Happened - MarketBeat
Anteris Grants 20,000 Unquoted RSUs Under Employee Incentive Plan - TipRanks
Anteris Technologies Global Corp (AVR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
3.17%
자본화:
|
볼륨(24시간):